Non-dilutive funding and asset sale update
Filed with ASX · · 1 page · English
ECS Botanics Holdings Ltd (ASX: ECS) (“ECS” or the “Company”), a leading medicinal cannabis company, is pleased to update the market on the implementation of its new strategic initiatives. th As announced to the market on 14 June 2022 the Company set out its strategy to invest for growth using non-dilutive funding and focussing on the Victorian medicinal cannabis operation which offers the highest
Ecs Botanics Holdings Ltd on 6ix
Earlier from Ecs Botanics
- ECS Exports First Shipment to New Zealand
- Focussed Strategy to Maximise Growth
- Marketing, Operational & Revenue Update
- HY Report - Increasing Sales Drives Revenue Growth
- ECS delivers first shipment to the United Kingdom
Later from Ecs Botanics
- Appendix 4E Preliminary Final Report
- Sale of Tasmanian Assets
- Sale Completion of Tasmanian Assets
- Victorian Flood Update
- ECS Secures $9.9m Supply Agreement into Germany
Follow Ecs Botanics into a list and get an email when it puts out news.
Follow Ecs Botanics